vs
LINDBLAD EXPEDITIONS HOLDINGS, INC.（LIND）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
LINDBLAD EXPEDITIONS HOLDINGS, INC.的季度营收约是再鼎医药的1.4倍（$183.2M vs $127.1M），LINDBLAD EXPEDITIONS HOLDINGS, INC.同比增速更快（23.3% vs 17.1%），LINDBLAD EXPEDITIONS HOLDINGS, INC.自由现金流更多（$3.5M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs 9.2%）
林德布拉德探险控股是一家专业探险旅行企业，总部位于美国纽约。目前公司运营15艘探险邮轮，载客量从28人到150人不等，可为旅行者提供覆盖全球七大洲目的地的探险邮轮旅程。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
LIND vs ZLAB — 直观对比
营收规模更大
LIND
是对方的1.4倍
$127.1M
营收增速更快
LIND
高出6.1%
17.1%
自由现金流更多
LIND
多$30.2M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
9.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $183.2M | $127.1M |
| 净利润 | $-23.6M | — |
| 毛利率 | 40.3% | 51.0% |
| 营业利润率 | -3.0% | -54.6% |
| 净利率 | -12.9% | — |
| 营收同比 | 23.3% | 17.1% |
| 净利润同比 | 6.0% | — |
| 每股收益（稀释后） | $-0.45 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LINDZLAB
| Q4 25 | $183.2M | $127.1M | ||
| Q3 25 | $240.2M | $115.4M | ||
| Q2 25 | $167.9M | $109.1M | ||
| Q1 25 | $179.7M | $105.7M | ||
| Q4 24 | $148.6M | $108.5M | ||
| Q3 24 | $206.0M | $101.8M | ||
| Q2 24 | $136.5M | $100.1M | ||
| Q1 24 | $153.6M | $87.1M |
净利润LINDZLAB
| Q4 25 | $-23.6M | — | ||
| Q3 25 | $1.2M | $-36.0M | ||
| Q2 25 | $-8.5M | $-40.7M | ||
| Q1 25 | $1.2M | $-48.4M | ||
| Q4 24 | $-25.0M | — | ||
| Q3 24 | $22.5M | $-41.7M | ||
| Q2 24 | $-24.7M | $-80.3M | ||
| Q1 24 | $-4.0M | $-53.5M |
毛利率LINDZLAB
| Q4 25 | 40.3% | 51.0% | ||
| Q3 25 | 48.2% | 59.5% | ||
| Q2 25 | 45.6% | 60.6% | ||
| Q1 25 | 48.3% | 63.6% | ||
| Q4 24 | 42.5% | 61.5% | ||
| Q3 24 | 46.7% | 64.1% | ||
| Q2 24 | 39.2% | 64.9% | ||
| Q1 24 | 45.0% | 61.4% |
营业利润率LINDZLAB
| Q4 25 | -3.0% | -54.6% | ||
| Q3 25 | 15.0% | -42.3% | ||
| Q2 25 | 2.6% | -50.3% | ||
| Q1 25 | 5.9% | -53.3% | ||
| Q4 24 | -5.1% | -62.6% | ||
| Q3 24 | 14.3% | -66.6% | ||
| Q2 24 | -6.0% | -76.0% | ||
| Q1 24 | 5.1% | -80.7% |
净利率LINDZLAB
| Q4 25 | -12.9% | — | ||
| Q3 25 | 0.5% | -31.2% | ||
| Q2 25 | -5.1% | -37.3% | ||
| Q1 25 | 0.6% | -45.8% | ||
| Q4 24 | -16.9% | — | ||
| Q3 24 | 10.9% | -40.9% | ||
| Q2 24 | -18.1% | -80.2% | ||
| Q1 24 | -2.6% | -61.4% |
每股收益（稀释后）LINDZLAB
| Q4 25 | $-0.45 | $-0.05 | ||
| Q3 25 | $0.00 | $-0.03 | ||
| Q2 25 | $-0.18 | $-0.04 | ||
| Q1 25 | $0.00 | $-0.04 | ||
| Q4 24 | $-0.45 | $-0.09 | ||
| Q3 24 | $0.36 | $-0.04 | ||
| Q2 24 | $-0.48 | $-0.08 | ||
| Q1 24 | $-0.10 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $256.7M | $689.6M |
| 总债务越低越好 | $662.7M | — |
| 股东权益账面价值 | $-284.5M | $715.5M |
| 总资产 | $980.0M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LINDZLAB
| Q4 25 | $256.7M | $689.6M | ||
| Q3 25 | $261.8M | $717.2M | ||
| Q2 25 | $200.9M | $732.2M | ||
| Q1 25 | $188.9M | $757.3M | ||
| Q4 24 | $183.9M | $779.7M | ||
| Q3 24 | $193.9M | $616.1M | ||
| Q2 24 | $168.1M | $630.0M | ||
| Q1 24 | $177.7M | $650.8M |
总债务LINDZLAB
| Q4 25 | $662.7M | — | ||
| Q3 25 | $663.5M | — | ||
| Q2 25 | $627.3M | — | ||
| Q1 25 | $626.4M | — | ||
| Q4 24 | $625.5M | — | ||
| Q3 24 | $624.5M | — | ||
| Q2 24 | $623.6M | — | ||
| Q1 24 | $622.7M | — |
股东权益LINDZLAB
| Q4 25 | $-284.5M | $715.5M | ||
| Q3 25 | $-256.6M | $759.9M | ||
| Q2 25 | $-263.8M | $791.7M | ||
| Q1 25 | $-252.2M | $810.8M | ||
| Q4 24 | $-253.1M | $840.9M | ||
| Q3 24 | $-226.9M | $667.7M | ||
| Q2 24 | $-255.5M | $704.2M | ||
| Q1 24 | $-227.4M | $762.2M |
总资产LINDZLAB
| Q4 25 | $980.0M | $1.2B | ||
| Q3 25 | $976.5M | $1.2B | ||
| Q2 25 | $936.5M | $1.2B | ||
| Q1 25 | $908.8M | $1.2B | ||
| Q4 24 | $876.9M | $1.2B | ||
| Q3 24 | $889.8M | $985.3M | ||
| Q2 24 | $858.3M | $987.4M | ||
| Q1 24 | $868.0M | $988.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $3.5M | $-26.7M |
| 自由现金流率自由现金流/营收 | 1.9% | -21.0% |
| 资本支出强度资本支出/营收 | 6.0% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $63.8M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流LINDZLAB
| Q4 25 | $14.4M | $-26.0M | ||
| Q3 25 | $19.5M | $-32.0M | ||
| Q2 25 | $29.2M | $-31.0M | ||
| Q1 25 | $48.4M | $-61.7M | ||
| Q4 24 | $1.7M | $-55.8M | ||
| Q3 24 | $28.1M | $-26.8M | ||
| Q2 24 | $18.6M | $-42.2M | ||
| Q1 24 | $43.9M | $-90.1M |
自由现金流LINDZLAB
| Q4 25 | $3.5M | $-26.7M | ||
| Q3 25 | $11.9M | $-35.0M | ||
| Q2 25 | $13.5M | $-33.9M | ||
| Q1 25 | $35.0M | $-63.2M | ||
| Q4 24 | $-8.2M | $-58.4M | ||
| Q3 24 | $18.4M | $-28.2M | ||
| Q2 24 | $11.2M | $-42.9M | ||
| Q1 24 | $37.4M | $-91.1M |
自由现金流率LINDZLAB
| Q4 25 | 1.9% | -21.0% | ||
| Q3 25 | 5.0% | -30.4% | ||
| Q2 25 | 8.0% | -31.1% | ||
| Q1 25 | 19.5% | -59.9% | ||
| Q4 24 | -5.5% | -53.8% | ||
| Q3 24 | 8.9% | -27.7% | ||
| Q2 24 | 8.2% | -42.9% | ||
| Q1 24 | 24.4% | -104.5% |
资本支出强度LINDZLAB
| Q4 25 | 6.0% | 0.5% | ||
| Q3 25 | 3.2% | 2.6% | ||
| Q2 25 | 9.4% | 2.6% | ||
| Q1 25 | 7.5% | 1.5% | ||
| Q4 24 | 6.6% | 2.4% | ||
| Q3 24 | 4.7% | 1.3% | ||
| Q2 24 | 5.4% | 0.7% | ||
| Q1 24 | 4.2% | 1.1% |
现金转化率LINDZLAB
| Q4 25 | — | — | ||
| Q3 25 | 16.41× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 41.69× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.25× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LIND
| Guest Ticket | $96.5M | 53% |
| Landexperience | $67.3M | 37% |
| Other Tour | $19.4M | 11% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
